InsidersTradesSigma
Follow the VITRAFY LIFE SCIENCES LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the supervision of ASX. Market capitalisation: €274.5m. The latest transaction was reported on 8 July 2026 (Mixed). Among the most active insiders: Brenton (Brent) Owens. The full history is free.
Analysts rate VITRAFY LIFE SCIENCES LIMITED Strong Buy (bullish), based on 2 analysts. Average price target: A$4.98.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
VITRAFY LIFE SCIENCES LIMITED es una empresa que cotiza en la ASX, especializada en el sector de las ciencias de la vida. Se centra en el desarrollo de soluciones innovadoras para mejorar la salud y el bienestar.